Those tumors with HRD were all diagnosed as high grade serous carcinoma, specifically harboring fusions involving NRG1 and the JAG1, SPON1, and TNFRSF12A partner genes. This evidence concerns the gene SPON1 and hypoparathyroidism-retardation-dysmorphism syndrome.